Thrive Wealth Management
TMO icon

Thrive Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Thrive Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.66M Buy
2,460
+210
+9% +$125K 0.21% 54
2026
Q2 		$1.13M Sell
2,250
-292
-11% -$140K 0.14% 76
2026
Q1 		$1.25M Sell
2,542
-830
-25% -$450K 0.19% 61
2025
Q4 		$1.95M Sell
3,372
-138
-4% -$78K 0.29% 43
2025
Q3 		$1.7M Buy
3,510
+138
+4% +$64.2K 0.26% 45
2025
Q2 		$1.37M Buy
3,372
+355
+12% +$148K 0.22% 53
2025
Q1 		$1.5M Buy
3,017
+54
+2% +$29.2K 0.29% 40
2024
Q4 		$1.54M Sell
2,963
-247
-8% -$136K 0.28% 42
2024
Q3 		$1.99M Buy
3,210
+44
+1% +$26K 0.36% 34
2024
Q2 		$1.75M Buy
3,166
+47
+2% +$26.9K 0.34% 34
2024
Q1 		$1.81M Buy
3,119
+339
+12% +$190K 0.37% 33
2023
Q4 		$1.48M Sell
2,780
-141
-5% -$68.2K 0.33% 37
2023
Q3 		$1.48M Buy
2,921
+144
+5% +$76.7K 0.39% 32
2023
Q2 		$1.45M Sell
2,777
-236
-8% -$127K 0.38% 30
2023
Q1 		$1.74M Buy
3,013
+422
+16% +$238K 0.45% 27
2022
Q4 		$1.43M Buy
2,591
+111
+4% +$58.8K 0.41% 31
2022
Q3 		$1.26M Buy
2,480
+372
+18% +$208K 0.44% 32
2022
Q2 		$1.14M Buy
2,108
+396
+23% +$218K 0.4% 34
2022
Q1 		$1.01M Buy
1,712
+180
+12% +$103K 0.3% 40
2021
Q4 		$1.02M Buy
+1,532
New +$957K 0.35% 33

Other funds holding TMO

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Quilter Plc
Quilter Plc London, United Kingdom $6.95B AUM 39.67% 1-Year Est. Return
Canoe Financial
Canoe Financial Calgary, Alberta, Canada $8.31B AUM 20.77% 1-Year Est. Return
Sarasin & Partners
Sarasin & Partners London, United Kingdom $8.93B AUM 11.81% 1-Year Est. Return
James Hambro & Partners
James Hambro & Partners London, United Kingdom $2.87B AUM 19.92% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Egerton Capital (UK)
Egerton Capital (UK) London, United Kingdom $9.8B AUM 22.76% 1-Year Est. Return

Thrive Wealth Management's TMO Position: Q3 2026 in Review

Thrive Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 9.3% in Q3 2026, buying an estimated $125K and bringing the position to 2,460 shares worth $1.66M. The position accounts for 0.21% of the portfolio, ranked #54.

Thrive Wealth Management first reported a position in TMO in Q4 2021 and has held it in 20 quarters since. The position peaked at $1.99M in Q3 2024. 668 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Thrive Wealth Management held 2,460 shares of Thermo Fisher Scientific worth $1.66M as of Q3 2026.
  • Thrive Wealth Management bought 210 Thermo Fisher Scientific shares in Q3 2026, an estimated $125K.
  • Thermo Fisher Scientific made up 0.21% of Thrive Wealth Management's portfolio in Q3 2026, its #54 holding.
  • Thrive Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 20 quarters since.
  • Thrive Wealth Management's Thermo Fisher Scientific position peaked at $1.99M in Q3 2024.
  • 668 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Thrive Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.